You are here

  • Home
  • Archive
  • Volume 4, Issue Suppl 1
  • 23 Cyclin dependent kinase 1 : a novel regulator controlling type i interferon signaling and potential target for therapeutic intervention in sle

Article info

Article menu

Download PDFPDF

Parallel Session 8: Innate immunity and interferon
23 Cyclin dependent kinase 1 : a novel regulator controlling type i interferon signaling and potential target for therapeutic intervention in sle
Free

Authors

  • L Wu 1Renji Hospital- School of Medicine- Shanghai Jiao Tong University, Shanghai Institute of Rheumatology, Shanghai, China PubMed articlesGoogle scholar articles
  • B Qu 1Renji Hospital- School of Medicine- Shanghai Jiao Tong University, Shanghai Institute of Rheumatology, Shanghai, China PubMed articlesGoogle scholar articles
  • Y Qin 1Renji Hospital- School of Medicine- Shanghai Jiao Tong University, Shanghai Institute of Rheumatology, Shanghai, China PubMed articlesGoogle scholar articles
  • N Shen 1Renji Hospital- School of Medicine- Shanghai Jiao Tong University, Shanghai Institute of Rheumatology, Shanghai, China 2Medical Centre, The Centre for Autoimmune Genomics and Aetiology CAGE, Cincinnati- Ohio, USACincinnati Children’s Hospital PubMed articlesGoogle scholar articles

Citation

Wu L, Qu B, Qin Y, et al
23 Cyclin dependent kinase 1 : a novel regulator controlling type i interferon signaling and potential target for therapeutic intervention in sle
Lupus Science & Medicine 2017;4:doi: 10.1136/lupus-2017-000215.23

Publication history

  • First published March 24, 2017.
Online issue publication 
March 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions